Cargando…
Choice of Fluids in Severe Septic Patients - A Cost-effectiveness Analysis Informed by Recent Clinical Trials
Fluid resuscitation with colloids is an established second line therapy for septic patients. Evidence of relative efficacy outcomes is tempered by considerations of the relative costs of the individual fluids. An assessment of recent large clinical trials was performed, resulting in a ranking in the...
Autores principales: | Farrugia, Albert, Bansal, Megha, Balboni, Sonia, Kimber, Mary Clare, Martin, Gregory S, Cassar, Josephine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112378/ https://www.ncbi.nlm.nih.gov/pubmed/24330133 http://dx.doi.org/10.2174/1574887108666131213120816 |
Ejemplares similares
-
Relative Survival Benefit and Morbidity with Fluids in Severe Sepsis - A Network Meta-Analysis of Alternative Therapies
por: Bansal, M., et al.
Publicado: (2013) -
Issues in assessing products for the treatment of hemophilia – the intersection between efficacy, economics, and ethics
por: Farrugia, Albert, et al.
Publicado: (2015) -
Is Humerus a Good Choice for Intraosseous Access During Fluid Resuscitation in a Child with Severe Septic Shock?
por: Öztürk, Gökcan, et al.
Publicado: (2022) -
Use of albumin in spontaneous bacterial peritonitis is cost-effective
por: Farrugia, A, et al.
Publicado: (2015) -
Choice of vasopressor in septic shock: does it matter?
por: Patel, Gourang P, et al.
Publicado: (2007)